04.05.2026 • News

Maximilian Peter Heads Wacker Polymers

Maximilian Peter will take over as Head of the Polymers division on May 1, 2026. The previous head of the division, Peter Summo, will take over the management of the central Sales & Distribution division.

Maximilian Peter took over as Head of the Polymers division at Wacker on May 1, 2026. The chemical engineer with a doctorate has been with the company since 2012.

After holding positions in process development, he took over as Head of Group Development and was most recently responsible for Human Resources.

Maximilian Peter succeeds Peter Summo, who successfully managed the Polymers division for ten years. Summo will take over as Head of Central Sales & Distribution on May 1, 2026. The business administration graduate began his career at specialty chemicals manufacturer Akzo Nobel and joined Wacker in 1995, where he held various management positions.

"With Maximilian Peter and Peter Summo, we are filling two key positions at Wacker with experienced colleagues who have already made a decisive impact on the company with their expertise," says Christian Hartel, Chairman of the Wacker Executive Board, on the occasion of the changeover. "As head of the Polymers division, Maximilian Peter will continue to drive forward the division's regional expansion. Peter Summo will continue to drive forward Wacker's market and customer focus and promote sales excellence across the board. I wish them both every success in their new roles and look forward to working with them in the future," Hartel continued.

Maximilian Peter
Maximilian Peter, Head of the Polymers division
© Wacker

Company

Logo:

Wacker Chemie

Hanns-Seidel-Platz 4
81737 Munich
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.